Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy

• Toby A. Eyre,
• Harriet S. Walter,
• Sunil Iyengar,
• George Follows,
• Matthew Cross,
• Christopher P. Fox,
• Andrew Hodson,
• Josh Coats,
• Santosh Narat,
• Nick Morley,
• Martin J.S. Dyer,
• Graham P. Collins

Affiliations

Toby A. Eyre

Department of Haematology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust

Harriet S. Walter

The Ernest and Helen Scott Haematological Research Institute, University of Leicester

Sunil Iyengar

Department of Haematology, The Royal Marsden Hospital, London

George Follows

Department of Haematology, Addenbrooke’s Hospital NHS Trust, Cambridge

Matthew Cross

Department of Haematology, The Royal Marsden Hospital, London

Christopher P. Fox

Department of Haematology, Nottingham University Hospitals NHS Trust

Andrew Hodson

Department of Haematology, Ipswich Hospital

Josh Coats

Department of Haematology, NHS Tayside, Dundee

Santosh Narat

Department of Haematology, Western Sussex Hospitals NHS Foundation Trust, Worthing

Nick Morley

Department of Haematology, Ipswich Hospital

Martin J.S. Dyer

The Ernest and Helen Scott Haematological Research Institute, University of Leicester

Graham P. Collins

Department of Haematology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust